RANGER GOLD CORP. financials

RNGC CIK 0001434740

Source: EDGAR filings · Built 2026-06-19T03:04:22Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2023FY 2012FY 2011
Working Capital 1.22K 0 -3.24K 0 129.20K 237.34K
Net Debt 0
Return on Equity (ROE) 171.56% 663.09% -71.43% -115.54%
Return on Assets (ROA) -703.18% -69.87% -115.06%
Current Ratio 1.44× 0.00× 40.89× 222.82×
Cash Conversion Ratio 1.04× 1.07× 0.85× 1.00× 0.97× 1.02×
Accruals Ratio 0.31× -0.02× 0.02×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2023FY 2012FY 2011
Revenues 0 0 0 0 0 0
Cost of Goods and Services Sold 0 0
Gross Profit 0 0
Selling, General and Administrative Expense 8 0 0
Operating Expenses 27.85K 46.32K 21.50K
Operating Income (Loss) -27.85K -46.32K -21.50K -19.68K -98.72K -272.72K
Income Tax Expense (Benefit) 0 0 0 0
Net Income (Loss) Attributable to Parent -27.85K -44.16K -21.50K -19.68K -103.72K -292.72K
Weighted Average Number of Shares Outstanding, Basic 48.02M 46.75M
Earnings Per Share, Diluted $0.00 $0.00
Weighted Average Number of Shares Outstanding, Diluted 262.34M 248.02M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2023FY 2012FY 2011
Cash and Cash Equivalents, at Carrying Value 0 131.34K 237.31K
Assets, Current 3.96K 0 0 0 132.44K 238.41K
Assets 3.96K 0 0 0 148.44K 254.41K
Liabilities, Current 2.74K 0 3.24K 0 3.24K 1.07K
Liabilities 20.19K 0 3.24K 0
Stockholders' Equity Attributable to Parent -16.23K 0 -3.24K 0 145.20K 253.34K
Common Stock, Shares, Outstanding 242.67M 248.02M 248.02M 248.02M 48.02M 48.02M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2023FY 2012FY 2011
Net Cash Provided by (Used in) Operating Activities -29.06K -47.40K -18.26K -19.68K -100.98K -297.49K
Net Cash Provided by (Used in) Investing Activities -5.00K -36.00K
Net Cash Provided by (Used in) Financing Activities 29.06K 47.40K 18.26K 19.68K 0 300.00K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (RNGC CIK 0001434740), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

NGEN

NERVGEN PHARMA CORP.

VXRT

VAXART, INC.

ECPG

ENCORE CAPITAL GROUP, INC.